# Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial

> **NCT06883864** · NA · RECRUITING · sponsor: **Beijing Anzhen Hospital** · enrollment: 146 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Catheter Ablation
- Atrial Functional Mitral Regurgitation

## Interventions

- **PROCEDURE:** Catheter ablation plus medication
- **DRUG:** Medication
- **PROCEDURE:** (ELEVATE-AF X) experimental group
- **PROCEDURE:** (ELEVATE-AF X) control group

## Key facts

- **NCT ID:** NCT06883864
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2027-08-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06883864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06883864, "Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-08-09 from https://api.ai-analytics.org/clinical/NCT06883864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*